INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,518,750 | +104.1% | 575,000 | +130.0% | 0.85% | +250.0% |
| Q2 2021 | $7,115,000 | -30.4% | 250,000 | -16.7% | 0.24% | +6.1% |
| Q1 2021 | $10,218,000 | +2.3% | 300,000 | 0.0% | 0.23% | -4.2% |
| Q4 2020 | $9,987,000 | -11.2% | 300,000 | -14.3% | 0.24% | -45.0% |
| Q3 2020 | $11,249,000 | -9.2% | 350,000 | -22.2% | 0.43% | -8.5% |
| Q2 2020 | $12,393,000 | +113.4% | 450,000 | +24.2% | 0.47% | +75.2% |
| Q1 2020 | $5,807,000 | – | 362,273 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |